Hi Ryn
And just to follow up on the trials its not just about patient enrolment
I cannot put my finger on wether prof Thomas voight actually said, or i read it in one of his articles, i believe it may have come from that very good one on one podcast that was put out there
If you remember he made mention that for these results to be acceptable all machinery had to be tuned balanced to give the same readouts this was a very technical issue of major importance now as you can imagine australia ph2 was coordinated from one site
This 2b is to be coordinated from 13 sites so therefore you have 13 sites that have to be capable of producing the exact same result as though they were actually under the the same roof in one location
From what Thomas voight said this is a critical the collective of results under the exact same circumstance
So this in itself would be a huge logistical difference from the ph2 we did especially being over 4 different jurisdictions rule and regulation wise as well
- Forums
- ASX - By Stock
- PER
- Fresh Start
Fresh Start, page-6
-
-
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.66M |
Open | High | Low | Value | Volume |
10.5¢ | 10.5¢ | 9.8¢ | $58.09K | 574.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 38503 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 194063 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.099 |
2 | 108491 | 0.098 |
1 | 30927 | 0.097 |
1 | 10004 | 0.096 |
3 | 162157 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 194063 | 5 |
0.110 | 254663 | 3 |
0.115 | 1334300 | 6 |
0.120 | 381142 | 9 |
0.125 | 110429 | 2 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
PER (ASX) Chart |